These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35211419)

  • 1. Retraction: LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration
    Frontiers Editorial Office
    Front Oncol; 2022; 12():858846. PubMed ID: 35211419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway.
    Zhang J; Jiang P; Wang S; Cheng W; Fu S
    Front Oncol; 2021; 11():639980. PubMed ID: 33898314
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction: Extracellular vesicles long non-coding RNA AGAP2-AS1 contributes to cervical cancer cell proliferation through regulating the miR-3064-5p/SIRT1 axis.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1145873. PubMed ID: 36816952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA OIP5-AS1 Regulates the Warburg Effect Through miR-124-5p/IDH2/HIF-1α Pathway in Cervical Cancer.
    Li L; Ma Y; Maerkeya K; Reyanguly D; Han L
    Front Cell Dev Biol; 2021; 9():655018. PubMed ID: 34513821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].
    Onco Targets Ther; 2022; 15():681-682. PubMed ID: 35733651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():841478. PubMed ID: 35036363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA NR2F2-AS1 induces epithelial-mesenchymal transition of non-small cell lung cancer by modulating BVR/ATF-2 pathway via regulating miR-545-5p/c-Met axis.
    Liu C; Li QG; Zhou Y; Cao YY; Wei ZX; Jin YH; Wang X; Chen YY; Qi L; Geng JX; Liu F
    Am J Cancer Res; 2021; 11(10):4844-4865. PubMed ID: 34765296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p.
    Huang X; Shi H; Shi X; Jiang X
    J Biol Res (Thessalon); 2021 Aug; 28(1):20. PubMed ID: 34399848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA LIPE-AS1 Drives Prostate Cancer Progression by Functioning as a Competing Endogenous RNA for microRNA-654-3p and Thereby Upregulating Hepatoma-Derived Growth Factor.
    Tian B; Chunxiang E; Xiang Y; Teng P
    Urol Int; 2021; 105(9-10):875-890. PubMed ID: 34233322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction: Long non-coding RNA ELFN1-AS1 promoted colon cancer cell growth and migration via the miR-191-5p/special AT-rich sequence-binding protein 1 axis.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1322464. PubMed ID: 38074639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TNK2-AS1 regulated ox-LDL-stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR-150-5p.
    Cai T; Cui X; Zhang K; Zhang A; Liu B; Mu JJ
    J Cell Mol Med; 2019 Nov; 23(11):7289-7298. PubMed ID: 31468685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA OIP5-AS1 Promotes the Proliferation of Hemangioma Vascular Endothelial Cells via Regulating miR-195-5p/NOB1 Axis.
    Zhang J; Zhao T; Tian L; Li Y
    Front Pharmacol; 2019; 10():449. PubMed ID: 31068824
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.
    Ma WG; Shi SM; Chen L; Lou G; Feng XL
    J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
    Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
    Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.